LUNDBECK LLC for LUNDBECK LLC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2025 | $140,000 | Replaced |
| 3rd Quarter - Amendment | Oct 28, 2025 | $140,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues pertaining to Pharmacy Benefit Managers Step therapy reform -the Safe Step Act Neuroscience Drug Program - FY 2026 AgFDA Approps BRAIN Initiative - FY 2026 Labor-HHS Appropriations Migraine care - FY 2026 MilCon Approps Reauthorization of the Pediatric Priority Review Voucher program at the FDA Issues related to DTC advertising regulations Give Kids a Chance Act of 2025 H.R. 1262, S. 932 The HEADACHE Act of 2025 - H.R. 5536 National Plan for Epilepsy Act -- H.R. 1189, S. 494
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAYLEY ALEXANDER New | — |
| HEATHER STRAWN | — |
Medicare/Medicaid MMM
Issues pertaining to the 340B Drug Discount Program Issues pertaining to the implementation of the Inflation Reduction Act of 2022 Issues pertaining to Pharmacy Benefit Managers Issues pertaining to CMS Coverage of APS in LTC Issues pertaining to Medicares Six Protected Classes policy Medicare Part D Smoothing Benefit - FY 2026 Labor-HHS Appropriations Orphan drug exclusion in the Inflation Reduction Act - H.R. 946 - The ORPHAN Cures Act Small molecule discrepancy in the Inflation Reduction Act - H.R. 1492 & S. 832 - The EPIC Act Issues pertaining to the Most Favored Nation drug price setting policy Issues pertaining to migraine screening for women in Medicare - FY 2026 Labor-HHS Appropriations
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAYLEY ALEXANDER New | — |
| HEATHER STRAWN | — |
Trade (domestic/foreign) TRD
Tariffs on pharmaceutical products
| Lobbyist | Covered position, as disclosed |
|---|---|
| HAYLEY ALEXANDER | — |
| HEATHER STRAWN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.